Essential Thrombocythemia - 25 Studies Found

Completed : Anagrelide Retard in Essential Thrombocythemia
: Essential Thrombocythemia
: 2014-02-13
:
  • Drug: Anagrelide retard Overen
Not yet recruiting : Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea
: Essential Thrombocythemia
: 2017-04-17
:
  • Drug: Ruxolitinib Ruxolitinib

Completed : French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia
: Essential Thrombocythemia
: 2010-08-26
Completed : Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia
: Essential Thrombocythaemia
: 2010-02-08
:
  • Drug: Anagrelide
  • Drug: Hydroxyurea
Completed : The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)
: Essential Thrombocythaemia
: 2006-12-19
: Drug: anagrelide hydrochloride Anagrelide hydrochloride 0.5 mg per capsule; patients will be stable on a
Completed : Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
: Essential Thrombocythaemia
: 2010-10-28
:
  • Drug: Anagrelide retard

Completed : Pediatric Disease Registry in Essential Thrombocythaemia (ET)
: Essential Thrombocythemia (ET)
: 2010-09-08
Completed : Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
: Essential Thrombocythemia (ET)
: 2011-10-31
: Drug: SPD422 (anagrelide hydrochloride) Subjects will be continued on the dose of anagrelide that contro
Not yet recruiting : Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia
:
  • MPN
  • Essential Thrombocythemia

: 2015-10-13
:
  • Other: Aspirin therapy interruption

Recruiting : Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
:
  • Myelofibrosis
  • Essential Thrombocythemia

: 2016-11-01
Next >>>